10X Genomics, Inc. (TXG)
58.18
-0.92
(-1.56%)
USD |
NASDAQ |
Nov 13, 16:00
58.18
0.00 (0.00%)
After-Hours: 19:59
10X Genomics Market Cap : 7.650B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 7.771B |
| November 11, 2026 | 8.159B |
| November 10, 2026 | 8.271B |
| November 09, 2026 | 8.553B |
| November 06, 2026 | 7.795B |
| November 05, 2026 | 7.634B |
| November 04, 2026 | 8.878B |
| November 03, 2026 | 8.585B |
| November 02, 2026 | 8.029B |
| October 30, 2026 | 9.134B |
| October 29, 2026 | 10.62B |
| October 28, 2026 | 10.89B |
| October 27, 2026 | 10.16B |
| October 26, 2026 | 9.505B |
| October 23, 2026 | 9.322B |
| October 22, 2026 | 9.087B |
| October 21, 2026 | 9.848B |
| October 20, 2026 | 9.310B |
| October 19, 2026 | 9.105B |
| October 16, 2026 | 9.102B |
| October 15, 2026 | 9.431B |
| October 14, 2026 | 9.524B |
| October 13, 2026 | 9.353B |
| October 12, 2026 | 9.796B |
| October 09, 2026 | 10.51B |
| Date | Value |
|---|---|
| October 08, 2026 | 10.07B |
| October 07, 2026 | 9.914B |
| October 06, 2026 | 10.51B |
| October 05, 2026 | 12.73B |
| October 02, 2026 | 12.18B |
| October 01, 2026 | 11.56B |
| September 30, 2026 | 11.77B |
| September 29, 2026 | 11.73B |
| September 28, 2026 | 11.53B |
| September 25, 2026 | 11.17B |
| September 24, 2026 | 10.96B |
| September 23, 2026 | 9.852B |
| September 22, 2026 | 10.51B |
| September 21, 2026 | 10.31B |
| September 18, 2026 | 9.980B |
| September 17, 2026 | 10.03B |
| September 16, 2026 | 9.469B |
| September 15, 2026 | 9.692B |
| September 14, 2026 | 9.134B |
| September 11, 2026 | 8.936B |
| September 10, 2026 | 8.648B |
| September 09, 2026 | 8.767B |
| September 08, 2026 | 8.547B |
| September 04, 2026 | 8.162B |
| September 03, 2026 | 8.236B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 6.992B |
| Tempus AI, Inc. | 13.03B |
| Intellia Therapeutics, Inc. | 1.361B |
| Personalis, Inc. | 1.702B |
| Alamar Biosciences, Inc. (California) | 2.142B |
Market Cap Related Metrics
| PS Ratio | 12.14 |
| Price to Book Value | 9.128 |
| Price to Free Cash Flow | 80.06 |
| Price | 58.18 |
| Earnings Yield | -0.89% |